Aurora Cannabis Inc. (ACB)
| Market Cap | 322.22M |
| Revenue (ttm) | 222.96M |
| Net Income (ttm) | 3.49M |
| Shares Out | 54.88M |
| EPS (ttm) | 0.07 |
| PE Ratio | 92.30 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,835,689 |
| Open | 5.98 |
| Previous Close | 5.86 |
| Day's Range | 5.79 - 6.28 |
| 52-Week Range | 2.84 - 9.35 |
| Beta | 2.70 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Feb 5, 2025 |
About ACB
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, ... [Read more]
Financial Performance
In 2023, Aurora Cannabis's revenue was 270.28 million, an increase of 20.77% compared to the previous year's 223.80 million. Losses were -65.58 million, -91.97% less than in 2022.
Financial numbers in CAD Financial StatementsNews
Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia
Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia EDMONTON, AB , Feb. 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB)...
Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia
NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB , ...
Aurora Cannabis: Strong Buy On Blowout Results And Constructive Outlook
Last week, Aurora Cannabis reported blowout Q3/FY2025 results with sales, gross margins, profitability, and free cash flow reaching new all-time highs. As a leader in the medical cannabis space, the c...
3 Marijuana Stocks To Watch As Trading Momentum May Soon Rise
The patience of some marijuana stock investors is still being tested. The public sector for cannabis is a victim of uncertainty and fear in more grey areas. What this means is in the USA there is no f...
Aurora Cannabis Announces Supply Agreement with SNDL
NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis EDMONTON, AB , February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora")...
Aurora Cannabis: Remarkable Recovery
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins and generating solid cash flows. The company reported FQ3 revenues of C$88 million and a significant im...
Aurora Cannabis Inc. (ACB) Q3 2025 Earnings Call Transcript
Aurora Cannabis Inc. (NASDAQ:ACB) Q3 2025 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Kevin Niland - Director of Strategic Finance and Investor Relations Miguel Martin -...
Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings
Canada-based global medical cannabis company Aurora Cannabis Inc ACB reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to CA$64.4 million a year ago.
Aurora Cannabis Announces Fiscal 2025 Third Quarter Results
NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY Generates Record Net Income of $31.2 Mi...
Aurora Cannabis Launches First Domestically Grown Medical Cannabis Brand in Germany Under New Cultivation License
NASDAQ | TSX: ACB Investment in the region continues with the launch of IndiMed, the company's first locally grown brand in Germany EDMONTON, AB , Jan. 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NA...
Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB , Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, ann...
Top Canadian Cannabis Companies Poised for Market Growth in 2025
The cannabis industry remains a rapidly expanding sector, with significant growth expected in the coming years. In the United States alone, legal cannabis sales surpassed $25 billion in 2021 and are p...
Empowering the Next Generation: Aurora Announces German Internship Program
NASDAQ | TSX: ACB Company Launches Internships at Manufacturing Facility in Leuna, Germany to Cultivate Future Leaders in the Medical Cannabis Industry EDMONTON, AB , Jan. 10, 2025 /PRNewswire/ - Auro...
Cannabis sector limps into 2025 because ‘the gold rush is over'
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
2025 Outlook: The Best Canadian Cannabis Stocks to Watch Now
The cannabis industry continues to evolve rapidly, presenting unique investment opportunities, especially in Canadian cannabis stocks. With the U.S. cannabis market projected to exceed $40 billion by ...
Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect
NASDAQ | TSX: ACB The collaboration aims to broaden access of premium medical cannabis products to Australian patients EDMONTON, AB , Dec. 17, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (T...
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Cannabis stocks have faced significant challenges recently, driven by political uncertainty that has further weighed on a sector still struggling to regain its footing since the overhyped all-time hig...
Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Continues to Offer Greater Choice for Patients EDMONTON, AB , Nov. 26, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), th...
Marijuana Industry Could Stay in Limbo Under Trump
A hands-off policy on cannabis will be a bad outcome for a business already struggling with ambiguous laws.
Aurora Cannabis Expands Innovative Recreational Product Portfolio
NASDAQ | TSX: ACB Introduces New Products and Flavours across Greybeard, San Rafael '71 and Tasty's brands EDMONTON, AB , Nov. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), th...
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pre...
3 Marijuana Stocks For Today Watchlist
The future of cannabis investing rests in the hands of politicians who may not have the industry's best interests at heart. Right now, the majority of marijuana stocks are feeling the impact of cannab...
Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely
If controversial Republican Matt Gaetz manages to win confirmation as attorney general, his tenure at the Justice Department is expected to be positive for the cannabis industry.
Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say
A reality check around regulatory challenges facing the cannabis sector has taken hold among some of the leading financiers in the industry, as optimism around the promise of a legal market has faded.
Aurora Cannabis: Buy The Election Overreaction
Aurora Cannabis dropped over 10%, along with the broader cannabis market, due to concerns over U.S. election results. Despite this, Aurora has no U.S. cannabis operations and is unaffected. Aurora rep...